Cardinal Health’s Broad Profit Growth Raises Questions On Valuation Gap

Simply Wall St

Sat, February 14, 2026 at 10:12 AM GMT+9 3 min read

In this article:

CAH

+2.66%

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

Cardinal Health (NYSE:CAH) reported strong fourth quarter results, with double-digit profit growth across all five operating segments.

The pharmaceutical and specialty solutions segment was the main driver of profit growth in the period.

Management pointed to ongoing success in executing its business priorities and focus areas across the company.

Cardinal Health is a major healthcare services and products company that plays a central role in drug distribution and specialty solutions for providers and pharmacies. For investors, the latest quarter offers a look at how the business is performing across its different lines, not just in core pharmaceutical distribution. Seeing all five segments post double-digit profit growth provides a clearer picture of how diversified the earnings base currently is.

The emphasis on pharmaceutical and specialty solutions is also important if you follow longer term themes such as the growth of specialty medicines and more complex therapies in the healthcare system. As you think about NYSE:CAH, these results help frame where the company is putting its effort and how that is reflected in segment level profitability, which can inform your own view of risk, stability and potential opportunities.

Stay updated on the most important news stories for Cardinal Health by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Cardinal Health.

NYSE:CAH Earnings & Revenue Growth as at Feb 2026

Is Cardinal Health’s dividend sustainable? Check out what every dividend investor needs to know in our dividend analysis.

Quick Assessment

**⚖️ Price vs Analyst Target**: The share price of US$220.79 sits about 11% below the US$247.80 analyst consensus target, so it is not far from the range analysts have in mind.

**✅ Simply Wall St Valuation**: The shares are described as trading about 55.5% below an estimated fair value, which flags a potential value gap to investigate.

**✅ Recent Momentum**: A roughly 3.4% gain over the last 30 days suggests the market has been reacting positively around the time of these results.

There is only one way to know the right time to buy, sell or hold Cardinal Health. Head to Simply Wall St’s company report for the latest analysis of Cardinal Health’s fair value.

Key Considerations

📊 Broad based double digit profit growth across all five segments supports the idea that earnings are not reliant on a single business line.

📊 Given the current P/E of about 31.3 and analyst targets, you might track how pharmaceutical and specialty solutions profits trend against earnings per share forecasts.

⚠️ The company has been flagged as having a high level of debt, so you may want to watch leverage and interest costs if growth in profits slows.

 






Story Continues  

Dig Deeper

For the full picture including more risks and rewards, check out the complete Cardinal Health analysis. Alternatively, you can visit the community page for Cardinal Health to see how other investors believe this latest news will impact the company’s narrative.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include CAH.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info